We have described recently the use of a test of intestinal permeability based on the simultaneous administration of two test substances,10 "1 cellobiose, a disaccharide, and mannitol, a polyhydric alcohol, both molecules being passively absorbed by the small intestinal mucosa. The test studies two aspects of altered permeability-namely, the decreased absorption of small molecules (mannitol), and the increased permeability to larger molecules (cellobiose) which are known to occur in mucosal diseases such as coeliac disease. By expressing the result as a ratio, cellobiose/mannitol, we have shown good separation between histologically normal and abnormal mucosae.'0 11 Moreover, as the effects of nonmucosal factors such as renal failure or small bowel contamination tend to be similar for both molecules, we have found that the cellobiose/mannitol ratio is not affected by such disturbances (unpublished) 
Malabsorption of nutrients in one form or another is a recognised complication of systemic sclerosis, occurring in from 10% to 30% of patients. ' Among the aetiological factors which have been documented are pancreatic dysfunction2 and small intestinal bacterial overgrowth,3 but other suggested causes include impaired intestinal motility, relative intestinal ischaemia, lymphatic obstruction, and altered permeability due to involvement of the intestinal wall by fibrosis. ' Biopsies of the jejunum have usually been reported as showing either no abnormality or a minimal inflammatory infiltrate,4 although one series of selected cases described fibrosis of Brunner's glands in six out of eight specimens.5
It is generally accepted that malabsorption in systemic sclerosis is unlikely to be due to a direct decrease in intestinal mucosal permeability. ' We have described recently the use of a test of intestinal permeability based on the simultaneous administration of two test substances,10 "1 cellobiose, a disaccharide, and mannitol, a polyhydric alcohol, both molecules being passively absorbed by the small intestinal mucosa. The test studies two aspects of altered permeability-namely, the decreased absorption of small molecules (mannitol), and the increased permeability to larger molecules (cellobiose) which are known to occur in mucosal diseases such as coeliac disease. By expressing the result as a ratio, cellobiose/mannitol, we have shown good separation between histologically normal and abnormal mucosae.'0 11 Moreover, as the effects of nonmucosal factors such as renal failure or small bowel contamination tend to be similar for both molecules, we have found that the cellobiose/mannitol ratio is not affected by such disturbances (unpublished) This study presents the jejunal biopsy findings in 17 unselected patients with systemic sclerosis, together with the results for the cellobiose/mannitol, and routine xylose tests. The results are correlated with general disease severity, gastrointestinal symptoms, the presence or absence of bacterial overgrowth, and the findings of small bowel radiology. 293 Methods Successful biopsies were obtained from the small bowel in 17 unselected patients with systemic sclerosis. In five cases, samples were obtained from the jejunum and duodenal loop using a Quinton hydraulic biopsy capsule. In one case, biopsies from the second part of the duodenum were obtained at fibreoptic endoscopy. In the remainder, a Crosby capsule (Watson model) was used to obtain samples from the distal duodenum or proximal jejunum.
The seventeen patients comprised 15 women and two men, with ages ranging from 15 to 67 years.
All of the patients had Raynaud's phenomenon and typical acrosclerotic cutaneous features of systemic sclerosis, although there was considerable variation in the degree of clinical severity of the disease in this unselected group of patients.
The degree of visceral involve:nent, and hence general disease severity, was quantitatively assessed in each patient using the criteria des^ribed by Hughes et al. '2 This index makes use of a scoring system, with points allotted on the basis of involvement of skin, lungs, gastrointestinal tract (in particular radiological involvemnent of oesophagus and/or colon), heart, kidneys, or the presence of other abnormalities-for example, Sjogren's syndrome. The higher the 'score' for a given patient, the greater the degree of visceral involvement.
Biopsies were sectioned at three levels and stained by haematoxylin and eosin. A further section of level 2 was stained by the periodic acid-Schiff method. The following changes were sought and if present graded as mild, moderate or severe: (1) villous atrophy; (2) lamina propria fibrosis; (3) thickening of the muscularis mucosa; (4) submucosa fibrosis; and (5) fibrosis of Brunner's glands.
Cellobiose/mannitol tests were carried out as previously described.10 11 Patients drank a hypertonic solution containing 2 g mannitol and 5 g cellobiose after fasting overnight, and urine was collected for five hours. The recovery of each was expressed as a percentage of the oral dose, and the ratio cellobiose (mg)/mannitol (mg) calculated.
Standard five hour urine xylose tests were performed in the fasting state using a 5 g dose. For our laboratory the lower limit of the normal range is 24% of the 5 g dose re:overed in five hours.
Radiological examination was performed by small bowel meal.'3 The criteria of involvement were dilatation, crowding of folds, hypomotility, sacculation, and stricture.'4 Upper limits of normal calibre (Fig. 2) , including one of the two biopsies demonstrating thickening of the muscularis mucosae.
In all, only four biopsies showed abnormalities and these were classified as mild in all cases.
PERMEABILITY (Fig. 3 , Table) The results for the cellobiose/mannitol test are shown in Fig. 3 
Discussion
This study, which represents one of the largest series of intestinal biopsy findings in systemic sclerosis, confirms the results of most previous workers. Thus, in 13 biopsies (76%) no abnormality was seen, and in the other four (24%) the changes were very mild.
The significance of such minor changes in villous architecture in association with skin disease has been disputed. '6 Of the six cases in whom Brunner's glands were seen, two showed mild fibrosis, and it may be that, had glands been present in all biopsies, we might have identified more cases with these mild abnormalities. The incidence is still less than that found by Rosson and Yesner5 (six out of eight), especially when we consider that submucosal changes were not seen in any of the 12 biopsies in which this area could be assessed. However, our series was unselected, whereas all their patients had clinical evidence of gastrointestinal involvement. In one other unselected series, there were no abnormalities found in 11 biopsies.4 Interestingly, the same study reported radiological changes in the small bowel in 12 out of 21 patients, a much higher incidence than in our series (two out of 17). The radiological signs of small bowel involvement are described by Marshak and Lindner14 and consist mainly of hypomotility, dilatation, and crowding of mucosal folds. Sacculation and pseudodiverticula formation may occur and pneumatosis cystoides intestinalis has been described. There are no signs of inflammation and the mucosal folds are not thickened. Transit time depends largely upon the technique of examination and the range of normal is wide. However, a grossly prolonged time for the method used may occur in systemic sclerosis as a feature of hypomotility. Flocculation of contrast is not seen when modern stable media are used. The quoted incidence of small bowel involvement varies from 22% to 57%.41617 These differences probably reflect selection of cases and strictness of radiological interpretation. Our incidence of 12% is due to our patients being totally unselected, and our limitation of the signs of involvement to hypomotility, dilatation, crowding of folds and sacculation.
The Table summarises the clinical features and results of investigations in the 17 patients. It is interesting that intestinal involvement, as assessed by changes in radiology, biopsy, or the presence of bacterial overgrowth, appears to be independent of disease severity. Thus, of the six patients with the highest scores for visceral involvement (patients 2, 7, 9, 10, 11, 15) , only one (patient 2) had an abnormal biopsy, and one (patient 9) had overgrowth.
A recent publication18 describes a number of patients with intestinal pseudo-obstruction, some of whom had a diagnosis of systemic sclerosis. Jejunal biopsies showed abnormalities of villous architecture, including some with subtotal villous atrophy. These patients did not respond to gluten-free diet, but a number improved clinically with antibiotic therapy. The authors could not account for the biopsy changes, but did suggest that they might be related to bacterial overgrowth in the intestine, possibly compounded by the distension of the gut wall due to the pseudo-obstruction. Of our 17 patients, only one (patient 14) had had episodes of pseudo-obstruction, and her biopsy was entirely normal. High counts (>106 organisms/ml) of intestinal bacteria in jejunal aspirates were found in five patients (including the patient with pseudoobstructions), two of whom also had a positive glucose/hydrogen breath test for intestinal bacterial overgrowth.1920 Four of these five patients with evidence of intestinal bacterial overgrowth had normal biopsies and the other had partial villous atrophy of only very minor degree. Conversely, three patients with biopsy changes had no evidence of intestinal overgrowth. These findings would suggest that bacterial overgrowth per se is unlikely to be the cause of the abnormalities described by Schuffler et al.,18 although there may have been differences in degree of severity between their cases and our unselected group. Alternatively, changes they describe may, as they suggest, be related in some way to pseudo-obstruction, and not directly to the disease process.
The results suggest that passive permeability is unimpaired by the disease process. All patients had a normal cellobiose/mannitol ratio, which has previously been shown to be a sensitive index of permeability changes."1 This is confirmed by the lack of correlation between histological changes and xylose excretion, the frequency of abnormal xylose results being similar in the groups with normal (5/13) and abnormal histology (2/4). Changes in deeper structures might not be expected to alter passive permeability, but in any case only one of the two patients with villous atrophy had a low xylose result. Moreover, of the seven patients with a low xylose excretion, two had been shown to have small intestinal bacterial overgrowth, two had mild chronic renal impairment, and one was known to have a prolonged gastric emptying time.
In conclusion, we have found mild abnormalities on intestinal biopsy in four of 17 unselected systemic sclerosis patients (24%). In agreement with other workers who have shown normal absorptive function in systemic sclerosis,21 we would stress that malabsorption in a patient with systemic sclerosis is unlikely to be due to a change in intestinal mucosal permeability. A search for some other factor, such as small bowel bacterial overgrowth, which we have found in approximately one-third of unselected systemic sclerosis patients,20 is more likely to be rewarding. 
